Trend toward survival benefit seen for REM-inhibition in ALS

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the American Thoracic Society 2025 International Conference, held from May 18 to 21 in San Francisco.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup